Nass et al. [22] reported previously that coincident methylation in both CpG islands of CDH1 and the estrogen receptor gene increases with advancing disease, suggesting that malignant progression of ductal carcinomas involves the accumulation of multiple epigenetic hits. The gene discussed is CDH1; the disease is breast ductal adenocarcinoma.